Carl N Kraus Aquestive Therapeutics, Inc. (AQST) insider trading activity

AQST Quotes by TradingView

Carl N Kraus is Chief Medical Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 313,566 shares of AQST, which is worth approximately $893,663. The most recent transaction as insider was on Mar 07, 2025, when has been sold 8,115 shares (Common Stock) at a price of $2.65 per share, resulting in proceeds of $21,504. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 314K
24.59% 3M change
19.45% 12M change
Total Value Held $893,663

Carl N Kraus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2025
SELL
Payment of exercise price or tax liability
$21,504 $2.65 p/Share
8,115 Reduced 2.52%
313,566 Common Stock
Mar 07 2025
BUY
Grant, award, or other acquisition
-
70,000 Added 17.87%
321,681 Common Stock
Aug 09 2024
SELL
Payment of exercise price or tax liability
$37,109 $3.43 p/Share
10,819 Reduced 4.12%
251,681 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
112,500 Added 30.0%
262,500 Common Stock
Aug 09 2023
BUY
Grant, award, or other acquisition
-
150,000 Added 50.0%
150,000 Common Stock

Also insider at

IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
CHIEF MEDICAL OFFICER
CNK

Carl N Kraus

Chief Medical Officer
Exton, PA

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AQST